Ostrum Asset Management »

Royalty Pharma shares owned by Ostrum Asset Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Ostrum Asset Management from 13F filings

Historical chart of Ostrum Asset Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Ostrum Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Ostrum Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.8M 140k 27.14
2023-06-30 $5.2M 169k 30.74
2023-03-31 $6.1M 169k 36.03

More positions owned by Ostrum Asset Management

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Spdr S&p 500 Etf Tr Exchange Traded Fund (SPY)
Amazon Common Stock (AMZN)
Nvidia Corporation Common Stock (NVDA)
Alphabet Common Stock (GOOG)
Unitedhealth Group Common Stock (UNH)
Johnson & Johnson Common Stock (JNJ)
Visa Common Stock (V)
Thermo Fisher Scientific Common Stock (TMO)
Alphabet Common Stock (GOOGL)
International Business Machs Common Stock (IBM)
Verizon Communications Common Stock (VZ)
Cboe Global Mkts Common Stock (CBOE)
Amgen Common Stock (AMGN)

View all positions for Ostrum Asset Management

Top funds holding Royalty Pharma

Vanguard Group
Baillie Gifford & Co
Viking Global Investors
Jpmorgan Chase & Co
Unisphere Establishment
Norges Bank Investment Management
Amundi
Siguler Guff Advisers
Legal & General Group
Goldman Sachs Group
Man Group
CalPERS
Two Sigma Investments
Two Sigma Advisers
Henderson Group

View all funds holding Royalty Pharma